Calcium deposits in your arteries cannot be fully reversed with any current medication or supplement. No drug therapy has been shown to remove calcium that has already hardened inside arterial walls. But that headline answer misses the more important picture: the calcium itself may not be your biggest threat, and there are proven ways to shrink the soft plaque underneath it, slow its progression, and dramatically cut your risk of a heart attack.
Why Arterial Calcium Is So Hard to Remove
Calcium deposits form inside arterial plaque over years as part of the body’s response to chronic inflammation in the vessel wall. Think of it like scar tissue hardening into bone. Once calcium crystallizes within a plaque, it becomes structurally embedded in the artery wall. Unlike a kidney stone sitting in a hollow tube, arterial calcium is woven into living tissue, which makes dissolving or extracting it without damaging the vessel extremely difficult.
This is why the medical focus has shifted away from trying to eliminate calcium and toward two different goals: stabilizing plaques so they don’t rupture, and slowing down new calcium from forming. A plaque that ruptures is what triggers most heart attacks, and heavily calcified plaques are actually more stable and less likely to rupture than soft, fatty ones. That distinction matters more than the number on your calcium score.
What Statins Actually Do to Calcium
If you’re on a statin and your coronary artery calcium (CAC) score goes up, that can feel alarming. But statins modestly accelerate calcification of existing plaques on purpose, in a sense. They convert soft, rupture-prone plaque into denser, more calcium-rich plaque that is less likely to crack open and cause a heart attack. Your Agatston score (the standard calcium scoring method) rises because it weighs density heavily, so denser plaque registers as a higher number even though the plaque is becoming safer.
Data from the CAC Consortium confirms that in statin users, calcium volume is a better predictor of heart disease risk than the standard Agatston score. Calcium density, the component statins increase, provided almost no additional predictive value for cardiovascular death in people taking statins. So a rising score on statins does not necessarily mean worsening disease. It can mean the opposite.
Shrinking the Plaque That Matters
While calcium itself doesn’t reverse, the fatty plaque surrounding and underneath it can shrink. The GLAGOV trial tested adding a powerful cholesterol-lowering injection to statin therapy and found that after 78 weeks, plaque volume decreased by nearly 1% in the treatment group while it slightly increased in the placebo group. That may sound small, but 64% of patients in the treatment group experienced measurable plaque regression, compared to 47% on statin therapy alone. Driving LDL cholesterol to very low levels appears to let the body gradually reabsorb some of the lipid-rich core of plaques.
Lifestyle Changes and Plaque Regression
The most striking evidence for reversing atherosclerosis without drugs comes from intensive lifestyle interventions. In a landmark trial led by Dean Ornish, patients who adopted a program of plant-based eating, regular exercise, stress management, and smoking cessation saw their arterial narrowing improve by about 8% over five years. Patients in the control group, who made only moderate changes, worsened by nearly 28% over the same period. The lifestyle group also experienced roughly half as many cardiac events.
These results reflect changes in the soft, fatty component of plaque rather than the calcium itself. The arteries opened up because the disease process partially reversed, not because calcium dissolved. This is a critical distinction: the blockage improved even though the calcium likely remained. What changed was the underlying disease activity.
Vitamin K2: Promising but Unproven
Vitamin K2 has gained attention because it activates a protein that helps direct calcium away from arteries and into bones. A 2023 randomized controlled trial published in JACC: Advances tested high-dose vitamin K2 (720 micrograms daily) combined with vitamin D for two years in men with coronary artery disease. Both groups saw their calcium scores increase over the study period. In patients who started with scores above 400, the supplemented group progressed somewhat less (an increase of 288 versus 380 points), a difference that was statistically significant. But K2 did not reverse existing calcium or stop progression entirely. It slowed it modestly in the most calcified patients.
Chelation Therapy Doesn’t Work
EDTA chelation therapy, which involves intravenous infusions of a compound that binds to metals and calcium, has been marketed for decades as a way to dissolve arterial calcium. An initial large trial (TACT) in 2013 reported an 18% reduction in cardiovascular events, with a particularly strong 41% reduction in patients with diabetes. This generated excitement, but a follow-up trial focused specifically on patients with diabetes and prior heart attacks found that chelation was not effective at reducing cardiovascular events despite successfully lowering blood lead levels. The current evidence does not support chelation as a treatment for coronary artery calcification.
Procedures That Break Up Calcium
When calcified plaque is severe enough to block blood flow or prevent a stent from expanding properly, cardiologists have two main tools. Rotational atherectomy uses a tiny diamond-tipped burr to physically grind away surface calcium inside the artery. It works, but only reaches superficial deposits and the size of the burr limits how much calcium it can remove.
A newer technique, intravascular lithotripsy, adapts the same technology used to break up kidney stones. A balloon catheter delivers sonic pressure waves that create microfractures in both shallow and deep calcium deposits. This doesn’t remove the calcium but cracks it enough to make the artery flexible again, allowing a stent to expand fully. The balloon inflates at just 4 atmospheres of pressure, far lower than conventional methods, which reduces the risk of tearing the vessel wall. Neither procedure reverses calcification throughout your arteries. They treat specific blockages that are causing problems.
How Fast Calcium Scores Typically Progress
If you already have a calcium score, it helps to know what’s normal. Coronary calcium scores typically increase by 20% to 25% per year. The rate depends heavily on risk factors, with diabetes being the strongest accelerator. Among people who start with a score of zero, about 6.6% per year develop detectable calcium for the first time. That rate climbs with age, from under 5% annually before age 50 to over 12% after age 80.
Knowing these baseline rates puts your own progression in context. If aggressive lifestyle changes or medication keep your annual increase well below 20%, that represents a meaningful slowing of disease even though the number continues to rise. The goal is not to reach zero. It is to flatten the curve and stabilize what’s already there.
What You Can Realistically Achieve
The honest answer is that you cannot reverse the calcium already in your arteries with any currently available treatment. But you can shrink the dangerous soft plaque around it, stabilize plaques so they’re far less likely to cause a heart attack, and slow or nearly halt the accumulation of new calcium. The combination of aggressive cholesterol lowering, blood pressure control, regular exercise, and a diet centered on whole foods has the strongest evidence behind it. Your calcium score may still creep up, but the disease underneath it can genuinely improve.